The Cooper Companies, based in San Ramon, California, employs 15,000 and operates through CooperVision, focused on contact lenses, and CooperSurgical, specializing in fertility and women's health solutions.
Based on our analysis, Cooper Companies has received a fairly valued rating of 2 out of 5 stars from Cashu. While the company demonstrates strong performance in several financial metrics, it also reveals areas of concern that contribute to its fair valuation status.
One key indicator is the Price-to-Earnings (P/E) ratio, which stands at 34.29 compared to the sector average of 13.90. A higher P/E ratio suggests that investors are willing to pay more for each dollar of earnings, but it can also indicate overvaluation if not supported by strong growth prospects. Additionally, the Return on Equity (ROE) ratio for Cooper Companies is 4.85, while the sector average is significantly lower at -75.69. Although this is a positive indicator of the company's ability to generate profit from shareholders' equity, the relatively low ROE raises questions about its efficiency compared to competitors.
Furthermore, Cooper Companies does not provide a dividend yield, standing at 0.00%, while the sector average is 0.19%. This lack of dividends may deter income-focused investors and reflects a preference for reinvesting profits rather than returning value to shareholders.
In summary, despite some strong financial performance metrics, Cooper Companies faces challenges that contribute to its fair valuation rating. Investors should weigh these factors carefully.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!